Biogen builds case for its Alzheimer’s drug
Biogen Inc has laid out more data on its experimental Alzheimer’s drug that raised no major safety
Biogen scraps Alzheimer’s trial, shares skid
Biogen and partner Eisai Co Ltd are ending two late-stage trials testing an Alzheimer’s drug, they